Dysregulated immunologic landscape of early host response in melioidosis.

Bacterial infections Expression profiling Immunology Infectious disease

Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
20 Aug 2024
Historique:
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 20 8 2024
Statut: aheadofprint

Résumé

Melioidosis, a neglected tropical infection caused by Burkholderia pseudomallei, commonly presents as pneumonia or sepsis with mortality rates up to 50% despite appropriate treatment. A better understanding of the early host immune response to melioidosis may lead to new therapeutic interventions and prognostication strategies to reduce disease burden. Whole blood transcriptomic signatures in 164 melioidosis patients and 70 patients with other infections hospitalized in northeastern Thailand enrolled within 24 hours following hospital admission were studied. Key findings were validated in an independent melioidosis cohort. Melioidosis was characterized by upregulation of interferon signaling responses compared to other infections. Mortality in melioidosis was associated with excessive inflammation, up-regulated type 2 immune responses and a dramatic decrease in T cell-mediated immunity compared to survivors. We identified and independently confirmed a five-gene predictive set classifying fatal melioidosis (validation cohort: an area under the receiver operating characteristic curve 0.83, 95% CI: 0.67-0.99). In conclusion, this study highlights the intricate balance between innate and adaptive immunity during fatal melioidosis and can inform future precision medicine strategies for targeted therapies and prognostication in this severe infection.

Identifiants

pubmed: 39163129
pii: 179106
doi: 10.1172/jci.insight.179106
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Patpong Rongkard (P)

NDM Centre for Global Health Research, Nuffield Department of Clinical Medi, University of Oxford, Oxford, United Kingdom.

Lu Xia (L)

Department of Statistics and Probability, Michigan State University, Lansing, United States of America.

Barbara Kronsteiner (B)

NDM Centre for Global Health Research, Nuffield Department of Clinical Medi, University of Oxford, Oxford, United Kingdom.

Thatcha Yimthin (T)

Department of Microbiology and Immunology, Mahidol University, Bangkok, Thailand.

Rungnapa Phunpang (R)

Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Adul Dulsuk (A)

Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Viriya Hantrakun (V)

Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Gumphol Wongsuvan (G)

Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Parinya Chamnan (P)

Cardiometablic Research Group, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.

Lara Lovelace-Macon (L)

Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, United States of America.

Emanuele Marchi (E)

Peter Medawar Building for Pathogen Research, Nuffield Department of Clinic, University of Oxford, Oxford, United Kingdom.

Nicholas Pj Day (NP)

NDM Centre for Global Health Research, Nuffield Department of Clinical Medi, University of Oxford, Oxford, United Kingdom.

Ali Shojaie (A)

Department of Biostatistics, University of Washington, Seattle, United States of America.

Direk Limmathurotsakul (D)

Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Narisara Chantratita (N)

Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Paul Klenerman (P)

Peter Medawar Building for Pathogen Research, Nuffield Department of Clinic, University of Oxford, Oxford, United Kingdom.

Susanna J Dunachie (SJ)

NDM Centre for Global Health Research, Nuffield Department of Clinical Medi, University of Oxford, Oxford, United Kingdom.

T Eoin West (TE)

Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, United States of America.

Sina A Gharib (SA)

Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, United States of America.

Classifications MeSH